Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failure.

G. Venkatesh; E. L. Fallen; M. V. Kamath; S. Connolly; S. Yusuf

doi:10.1136/hrt.76.2.137

Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failure.

Heart ◽

10.1136/hrt.76.2.137 ◽

1996 ◽

Vol 76 (2) ◽

pp. 137-143 ◽

Cited By ~ 13

Author(s):

G. Venkatesh ◽

E. L. Fallen ◽

M. V. Kamath ◽

S. Connolly ◽

S. Yusuf

Keyword(s):

Heart Failure ◽

Heart Rate ◽

Heart Rate Variability ◽

Chronic Heart Failure ◽

Controlled Trial ◽

Short Term ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Short-term effects of a 3-week interval training program on heart rate variability in chronic heart failure. A randomised controlled trial

Annals of Physical and Rehabilitation Medicine ◽

10.1016/j.rehab.2019.06.013 ◽

2019 ◽

Vol 62 (5) ◽

pp. 321-328 ◽

Cited By ~ 1

Author(s):

Florent Besnier ◽

Marc Labrunée ◽

Lisa Richard ◽

Florence Faggianelli ◽

Hélène Kerros ◽

...

Keyword(s):

Heart Failure ◽

Heart Rate ◽

Heart Rate Variability ◽

Chronic Heart Failure ◽

Randomised Controlled Trial ◽

Training Program ◽

Controlled Trial ◽

Interval Training ◽

Short Term ◽

Randomised Controlled

Download Full-text

Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure　– A Randomized, Double-Blind, Placebo-Controlled Phase II Study –

Circulation Journal ◽

10.1253/circj.cj-15-1112 ◽

2016 ◽

Vol 80 (3) ◽

pp. 668-676 ◽

Cited By ~ 18

Author(s):

Hiroyuki Tsutsui ◽

Shinichi Momomura ◽

Akira Yamashina ◽

Hisao Ogawa ◽

Hiroaki Shimokawa ◽

...

Keyword(s):

Heart Failure ◽

Heart Rate ◽

Chronic Heart Failure ◽

Phase Ii ◽

Rate Control ◽

Phase Ii Study ◽

Japanese Patients ◽

Heart Rate Control ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.

Circulation ◽

10.1161/01.cir.79.3.491 ◽

1989 ◽

Vol 79 (3) ◽

pp. 491-502 ◽

Cited By ~ 153

Author(s):

H Drexler ◽

U Banhardt ◽

T Meinertz ◽

H Wollschläger ◽

M Lehmann ◽

...

Keyword(s):

Heart Failure ◽

Congestive Heart Failure ◽

Controlled Trial ◽

Converting Enzyme ◽

Long Term Effects ◽

Short Term ◽

Double Blind ◽

Double Blind Placebo ◽

Converting Enzyme Inhibition

Download Full-text

A randomised, double‐blind, placebo‐controlled trial of metformin on myocardial efficiency in insulin‐resistant chronic heart failure patients without diabetes

European Journal of Heart Failure ◽

10.1002/ejhf.1656 ◽

2019 ◽

Vol 22 (9) ◽

pp. 1628-1637 ◽

Cited By ~ 8

Author(s):

Anders Hostrup Larsen ◽

Niels Jessen ◽

Helene Nørrelund ◽

Lars Poulsen Tolbod ◽

Hendrik Johannes Harms ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Heart Failure Patients ◽

Insulin Resistant ◽

Myocardial Efficiency

Download Full-text

The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT)

American Heart Journal ◽

10.1016/j.ahj.2020.09.020 ◽

2021 ◽

Vol 231 ◽

pp. 137-146

Author(s):

Henrik Wiggers ◽

Lars Køber ◽

Gunnar Gislason ◽

Morten Schou ◽

Mikael Kjær Poulsen ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Isosorbide Dinitrate ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Factorial Trial

Download Full-text

Influence of angiotensin converting enzyme inhibition on exercise performance and clinical symptoms in chronic heart failure: a multicentre, double-blind, placebo-controlled trial

European Heart Journal ◽

10.1093/eurheartj/14.suppl_c.18 ◽

1993 ◽

Vol 14 (suppl C) ◽

pp. 18-23 ◽

Cited By ~ 12

Author(s):

L. Dossegger ◽

E. Aldor ◽

M. G. Baird ◽

S. Braun ◽

J. G. F. Cleland ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Angiotensin Converting Enzyme ◽

Clinical Symptoms ◽

Controlled Trial ◽

Angiotensin Converting Enzyme Inhibition ◽

Converting Enzyme ◽

Double Blind ◽

Double Blind Placebo ◽

Converting Enzyme Inhibition

Download Full-text

A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome)

Medicine ◽

10.1097/md.0000000000020271 ◽

2020 ◽

Vol 99 (21) ◽

pp. e20271 ◽

Cited By ~ 1

Author(s):

Lijun Guo ◽

Hui Yuan ◽

Dawu Zhang ◽

Jian Zhang ◽

Qi Hua ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Controlled Trial ◽

Deficiency Syndrome ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Kidney Yang Deficiency

Download Full-text

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

The Lancet ◽

10.1016/s0140-6736(08)61240-4 ◽

2008 ◽

Vol 372 (9645) ◽

pp. 1231-1239 ◽

Cited By ~ 669

Author(s):

GISSI-HF investigators

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Chinese herbal medicine for chronic heart failure: a multicenter, randomized, double-blind, placebo-controlled trial

Journal of Traditional Chinese Medical Sciences ◽

10.1016/j.jtcms.2014.11.010 ◽

2014 ◽

Vol 1 (2) ◽

pp. 98-108 ◽

Cited By ~ 2

Author(s):

Liangtao Luo ◽

Juan Wang ◽

Aiqing Han ◽

Peng Zhang ◽

Shuzhen Guo ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Herbal Medicine ◽

Chinese Herbal Medicine ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Chinese Herbal

Download Full-text

Effect of Yangxinkang Tablets (养心康片) on chronic heart failure: A multi-center randomized double-blind placebo-controlled trial

Chinese Journal of Integrative Medicine ◽

10.1007/s11655-015-2170-x ◽

2015 ◽

Vol 21 (10) ◽

pp. 733-742 ◽

Cited By ~ 3

Author(s):

Shao-xiang Xian ◽

Zhong-qi Yang ◽

Pei-hua Ren ◽

Xiao-han Ye ◽

Sui-lin Ye ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failure.

Short-term effects of a 3-week interval training program on heart rate variability in chronic heart failure. A randomised controlled trial

Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure – A Randomized, Double-Blind, Placebo-Controlled Phase II Study –

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial.

A randomised, double‐blind, placebo‐controlled trial of metformin on myocardial efficiency in insulin‐resistant chronic heart failure patients without diabetes

Influence of angiotensin converting enzyme inhibition on exercise performance and clinical symptoms in chronic heart failure: a multicentre, double-blind, placebo-controlled trial

A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome)

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

Chinese herbal medicine for chronic heart failure: a multicenter, randomized, double-blind, placebo-controlled trial

Effect of Yangxinkang Tablets (养心康片) on chronic heart failure: A multi-center randomized double-blind placebo-controlled trial

Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure　– A Randomized, Double-Blind, Placebo-Controlled Phase II Study –